Suramin, a century-old antiparasitic medication, holds one of the longest plasma half-lives of any drug given to humans: roughly 44 to 54 days after the final dose, meaning it takes months to fully clear the bloodstream. But “staying in your system” depends on where you look. Bisphosphonate bone drugs can be detected in the skeleton for over a decade, and lead, while not a drug, lodges in bone with a half-life measured in years. The answer changes dramatically depending on whether you care about blood, urine, fat, bone, or hair, and whether you mean a recreational substance, a prescription medication, or a toxic exposure.
Fat-Soluble Drugs Hang Around in Adipose Tissue
The most familiar example for most people is THC, the psychoactive component of cannabis. THC is highly fat-soluble and accumulates in adipose tissue, where it can persist for weeks after a single use. Early research found that after one injection, the concentration of THC in fat was roughly ten times greater than in any other tissue examined and remained detectable for two weeks; with repeated exposure, THC and its metabolites continued to build up in fat and brain tissue.1PubMed. Delta-9-tetrahydrocannabinol: localization in body fat That stored THC does not just sit inert. Animal studies have shown that fasting or stress-hormone exposure can release fat-stored THC back into the bloodstream, a phenomenon sometimes called “reintoxication.”2PubMed Central. Reintoxication: the release of fat-stored delta(9)-tetrahydrocannabinol (THC) into blood is enhanced by food deprivation or ACTH exposure This is why chronic cannabis users can test positive on a urine drug screen for a month or more after quitting, while a single-use episode might only show up for a few days.
THC is not the only drug that hides in fat. Etretinate, a metabolite of the psoriasis drug acitretin, also has an extremely long retention time in adipose tissue. Because etretinate is a known teratogen, meaning it causes birth defects, women who take acitretin are advised to avoid pregnancy for years after stopping the medication.3PubMed Central. Clinical Factors Affecting the Serum Retention of a Teratogenic Etretinate after the Acitretin Administration The drug’s stubborn presence in fat makes it one of the most clinically consequential examples of prolonged drug retention, and a reminder that “out of your bloodstream” and “out of your body” are not the same thing.
Bone Is the Body’s Long-Term Storage Vault
If fat tissue holds drugs for weeks, bone can hold them for years. Bisphosphonates like alendronate, widely prescribed for osteoporosis, are designed to bind tightly to bone mineral. About 40 to 60 percent of a dose is retained in the skeleton for a very long time, with no evidence of saturation, meaning that every subsequent dose adds more drug to what is already there.4PubMed. Pharmacokinetics of alendronate The drug is slowly released only as bone naturally remodels, a process that takes years. This is actually by design: the slow release is what keeps suppressing bone breakdown long after a patient stops taking the pills. Estimates of alendronate’s terminal half-life in bone run to roughly a decade.
Lead, while technically a toxin rather than a drug, follows the same playbook and illustrates the principle even more starkly. After occupational or environmental exposure, lead migrates into bone, where it has a half-life of 5 to 19 years.5PubMed Central. Toxicokinetics of bone lead That stored lead can re-enter the bloodstream during periods of high bone turnover, such as pregnancy, breastfeeding, or aging, potentially causing harm long after the original exposure ended.6Environmental Health Perspectives. Bone lead as a new biologic marker of lead dose: recent findings and implications for public health This concept of “delayed toxicity” from bone-stored lead is one of the reasons public health researchers still worry about populations who were heavily exposed to leaded gasoline decades ago.
Suramin and Extreme Protein Binding
Back in the realm of actual pharmaceuticals, suramin stands apart. This drug, used primarily against African sleeping sickness, is approximately 99.7 percent bound to proteins in the blood, which shields it from being filtered out by the kidneys. After repeated dosing, its plasma half-life stretches to 44 to 54 days, described as one of the longest half-lives reported for any therapeutic substance given to humans.7PubMed. Clinical pharmacokinetics of suramin in patients with HTLV-III/LAV infection Even after a single low dose, target concentrations of suramin were maintained in the blood for up to six weeks.8PubMed Central. Low‐dose suramin in autism spectrum disorder: a small, phase I/II, randomized clinical trial
The mechanism is straightforward in principle. Most drugs circulate partly free in blood plasma and partly attached to blood proteins like albumin. Only the free, unbound fraction can be metabolized and excreted. When a drug is 99.7 percent bound, the tiny free fraction gets cleared, but then more drug unbinds from its protein reservoir, and the cycle continues very slowly. Suramin is the extreme case, but many drugs with high protein binding, including some anti-seizure and anti-clotting medications, have similarly extended elimination times relative to their class.
Why Benzodiazepines Show Up for Weeks
Among recreational and commonly prescribed substances, benzodiazepines are notorious for long detection windows on drug tests. Diazepam (Valium) is the classic example. The parent drug has a half-life of about 120 hours, but its active metabolites stick around far longer. A pharmacokinetic study in healthy volunteers found that the metabolite oxazepam glucuronide had a half-life of over 536 hours, roughly 22 days. Both diazepam and its main metabolites remained detectable in urine for at least 15 days, with significant variation between individuals.9PubMed Central. Pharmacokinetics of Diazepam and Its Metabolites in Urine of Chinese Participants In chronic users, positive urine tests can persist even longer because the drug and its metabolites accumulate with repeated dosing.
This matters practically for anyone undergoing drug testing. A person who takes a single dose of diazepam might reasonably assume it would clear in a couple of days, the way a short-acting benzodiazepine like alprazolam might. But diazepam’s cascade of long-lived metabolites means the detection window is measured in weeks, not days.
Engineered to Last: Long-Acting Injectables and Biologics
Some drugs are deliberately designed to stay in the body for extended periods. Long-acting injectable antipsychotics, used in schizophrenia treatment, are formulated by attaching the drug molecule to a fatty acid chain and dissolving it in oil. When injected into muscle, the oil depot releases the drug slowly over weeks. A single intramuscular injection given at one- to four-week intervals produces adequate plasma concentrations to prevent relapse throughout the dosing period.10PubMed. The pharmacokinetics of long-acting antipsychotic medications These formulations exhibit what pharmacologists call “flip-flop” kinetics: the rate-limiting step is not how fast the body eliminates the drug, but how slowly the drug absorbs from the injection site.
Monoclonal antibody therapies take the concept even further. These are large protein molecules, engineered versions of the antibodies your immune system naturally produces. Like natural antibodies, they are protected from degradation by a receptor called FcRn, which recycles them back into circulation instead of letting them be broken down. This gives therapeutic monoclonal antibodies elimination half-lives of up to four weeks.11PubMed. Clinical pharmacokinetics of therapeutic monoclonal antibodies Some newer antibody therapies are dosed only once every few months, staying active in the body between appointments. If you have received an infusion for an autoimmune condition or cancer, that drug might remain measurable in your blood for weeks after the infusion bag was disconnected.
Mechanisms That Extend a Drug’s Stay
Several biological processes can keep a drug circulating longer than its basic chemistry would suggest. Enterohepatic recirculation is one of the more important. The liver processes a drug and dumps it into bile, which flows into the intestine. But instead of being excreted, the drug gets reabsorbed from the gut and returns to the liver, starting the cycle over. This recycling loop can produce multiple peaks in blood concentration and a much longer apparent half-life than the drug would have without it.12PubMed. Enterohepatic circulation: physiological, pharmacokinetic and clinical implications A modeling study on apixaban, a blood thinner, found that removing the enterohepatic recycling component from the model shortened the drug’s predicted half-life from about 8.7 hours to 2.9 hours, illustrating how substantially this process can extend drug exposure.13PubMed Central. Characterizing Apixaban Pharmacokinetics Through Physiologically-Based Pharmacokinetic Modeling: Critical Role of Biliary Secretion and Enterohepatic Circulation in Humans
Melanin binding is another mechanism, particularly relevant in the eye. Chloroquine and hydroxychloroquine, drugs used for malaria and autoimmune diseases, display a strong physical attraction to melanin, the pigment found in the retina and skin.14PubMed Central. Chloroquine and hydroxychloroquine binding to melanin: Some possible consequences for pathologies The drugs bioaccumulate in melanin-rich retinal tissue, which is why long-term hydroxychloroquine users need regular eye exams to screen for retinal toxicity. The drug essentially glues itself to the pigment and persists locally even after blood levels have dropped.
Covalent, irreversible binding represents the most extreme version of this concept. Some drugs, like aspirin and certain cancer therapies, work by forming a permanent chemical bond with their target protein. Once the bond is made, no amount of metabolism or excretion breaks it. The drug’s effect lasts until the body manufactures new copies of the target protein, which can take days. Covalent inhibitors are valued precisely because their duration of action outlasts their measurable presence in the bloodstream.15PubMed Central. Strategies for discovering and derisking covalent, irreversible enzyme inhibitors Aspirin’s irreversible inactivation of the clotting enzyme in platelets is why a single baby aspirin can affect bleeding for a week or more, even though the aspirin itself is gone from the blood within hours.
Your Genetics and Health Change the Timeline
Two people can take the same dose of the same drug and have vastly different elimination times. A major reason is genetic variation in drug-metabolizing enzymes, particularly the CYP2D6 enzyme. About 7 percent of people of European descent are “poor metabolizers” who carry gene variants that produce little or no functional CYP2D6. These individuals clear CYP2D6-dependent drugs much more slowly than the general population.16PubMed Central. Molecular genetics of CYP2D6: clinical relevance with focus on psychotropic drugs At the other end of the spectrum, “ultrarapid metabolizers” carry extra copies of the gene and break down drugs unusually fast, sometimes too fast for the drug to work.
Age, sex, and organ function also matter. Older adults, and older women in particular, tend to achieve higher blood concentrations of many drugs because of changes in body composition, liver function, and enzyme activity.17PubMed Central. The role of sex, age and genetic polymorphisms of CYP enzymes on the pharmacokinetics of anticholinergic drugs Kidney disease has an even more dramatic effect. For small protein-based drugs in people with significant renal impairment, drug clearance drops by about 30 percent on average and half-life can increase roughly threefold.18PubMed Central. Pharmacokinetic predictions for patients with renal impairment: focus on peptides and protein drugs Liver disease similarly slows the metabolism of drugs that depend on hepatic processing. If you have impaired kidney or liver function, drugs that typically clear within days might linger for a week or more.
Detection Windows Depend on What Gets Tested
When people ask “how long does a drug stay in your system,” they usually mean “how long will it show up on a test.” That answer depends entirely on the specimen. Urine testing is the standard for most workplace and legal drug screens, and it detects metabolites, not the parent drug itself. Blood testing reflects more recent use. Saliva and fingerprints are newer matrices with their own quirks: drug concentration time-courses in saliva tend to mirror blood, while fingerprint concentrations more closely track urine.19PubMed. Effectiveness of saliva and fingerprints as alternative specimens to urine and blood in forensic drug testing Some compounds, like ibuprofen, are harder to detect in all specimen types because they are acidic and do not concentrate well in these fluids.
Hair testing is in a category by itself. Drugs are incorporated into the hair shaft as the hair grows, creating a timeline of exposure that extends back months. Research using mass spectrometry imaging has shown that drugs enter hair through at least two incorporation sites, including in the keratinized shaft within the upper dermis, which creates overlapping drug bands that move outward with growth.20PubMed. Time-course mass spectrometry imaging for depicting drug incorporation into hair A standard hair test typically covers a 90-day window based on about 1.5 inches of growth from the scalp. For drugs like cocaine, opioids, and amphetamines, hair testing can reveal use that occurred months ago, long after urine and blood have cleared.
Do Detox Products Actually Speed Elimination?
A cottage industry of “detoxification” drinks, capsules, and kits promises to flush drugs from your system before a test. The reality is less encouraging. People try to beat drug tests in two main ways: ingesting products marketed as detoxifiers to wash out drugs, or adding adulterants directly to a urine sample. Drug-testing laboratories are well aware of both strategies and routinely run specimen validity tests that check pH, creatinine, specific gravity, and temperature, along with specialized tests to identify common adulterants like oxidants and pyridinium chlorochromate.21PubMed. Beating Drug Tests by Ingesting Detoxifying Agents or Adulterating Urine in vitro: Are These Practices Effective? A sample that fails a validity test is flagged as suspicious, which in many employment and legal contexts is treated the same as a positive result.
The detox drinks themselves generally work by diluting urine through heavy water intake, sometimes with added creatine and B-vitamins to mask the dilution. This might lower metabolite concentrations below the cutoff for a brief window, but it does nothing to actually remove the drug from fat stores, bone, or other tissue. For someone with substantial THC accumulated in adipose tissue, for example, the drug will continue seeping back into the bloodstream long after the detox drink’s effects have worn off. The most reliable way to pass a drug test remains the least marketable advice: stop using the substance and wait.
Drugs That Outlast Their Blood Levels
One common misconception is that a drug’s elimination from the bloodstream means its effects are over. Covalent inhibitors, as discussed, are the clearest counterexample. But the principle applies broadly. Bisphosphonates continue suppressing bone resorption for years after the last pill. Hydroxychloroquine bound to retinal melanin can damage the eye long after the prescription has ended. And stored THC released from fat during weight loss or stress can produce measurable blood levels, and potentially mild psychoactive effects, without any new cannabis use. The body is not a pipe through which drugs simply flow and exit. It is a landscape of compartments, each with its own capacity to absorb, store, and eventually release whatever chemical happened to find its way there.